Beachbody vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 20)

Beachbody

EmergingFitness & Wellness

Digital Fitness

Home fitness streaming platform behind P90X and Insanity; BODi subscription competing with Peloton and Apple Fitness+ after pivoting away from MLM coach distribution model.

AI VisibilityBeta
Overall Score
D20
Category Rank
#1 of 1
AI Consensus
55%
Trend
stable
Per Platform
ChatGPT
25
Perplexity
12
Gemini
22

About

Beachbody is a direct-to-consumer home fitness company known for producing iconic workout programs (P90X, Insanity, 21 Day Fix, T25, LIIFT4) delivered through its Beachbody On Demand subscription streaming service, alongside nutritional supplement products under the Shakeology brand. Founded in 1998 in Santa Monica, California by Carl Daikeler and Jon Congdon, Beachbody went public via SPAC in 2021 under BODi (NYSE: BODY), but the public market journey was difficult — the company underwent significant restructuring and moved away from its multi-level marketing coach network in favor of direct digital marketing.\n\nBeachbody's workout programs are structured multi-week fitness plans (P90X is a 90-day extreme home workout program) delivered as streaming video workouts through the Beachbody On Demand platform, with subscription access to the full program library. The company's pivot from the trainer/coach MLM distribution model to digital direct-to-consumer subscription reflected broader changes in how fitness content is discovered and purchased. Shakeology, the protein shake and meal replacement supplement, generates significant recurring revenue from loyal customers who subscribe to monthly delivery.\n\nIn 2025, Beachbody/BODi operates in the competitive digital fitness market with Peloton (equipment + content), Nike Training Club (free), Apple Fitness+, and Les Mills On Demand for streaming workout subscription market share. The home fitness market experienced a COVID boom in 2020-2021 followed by significant normalization as gyms reopened — Peloton faced severe financial difficulties and Beachbody's public market valuation declined substantially. The 2025 strategy focuses on the BODi subscription service as the core product, simplifying the coach/affiliate program that defined the old model, and growing through digital acquisition rather than MLM-style recruitment, competing on program quality and community.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

20
Overall Score
90
#1
Category Rank
#9
55
AI Consensus
60
stable
Trend
stable
25
ChatGPT
99
12
Perplexity
99
22
Gemini
83
27
Claude
96
11
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.